Halozyme Therapeutics
HALO
₹5,293
Share price
-3.04%
Change (1 day)
53.66%
Change (1 year)
Categories
Halozyme Therapeutics (HALO) - Total debt
Total debt on the balance sheet as of December 2024 : ₹128.82 Billion
According to Halozyme Therapeutics's latest financial reports the company's total debt is ₹128.82 Billion. A company’s total debt is the sum of all current and non-current debts.
Halozyme Therapeutics - Total debt on balance sheet (from 2011 to 2024)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2024-12-31 | ₹129.17 B | 3.5% |
| 2023-12-31 | ₹124.81 B | 0.15% |
| 2022-12-31 | ₹124.62 B | 91% |
| 2021-12-31 | ₹65.25 B | 124.61% |
| 2020-12-31 | ₹29.05 B | 1.19% |
| 2019-12-31 | ₹28.70 B | 224.88% |
| 2018-12-31 | ₹8.83 B | -31.61% |
| 2017-12-31 | ₹12.92 B | -12.23% |
| 2016-12-31 | ₹14.72 B | 344.5% |
| 2015-12-31 | ₹3.31 B | 4.8% |
| 2014-12-31 | ₹3.16 B | 2.77% |
| 2013-12-31 | ₹3.07 B | 80.51% |
| 2012-12-31 | ₹1.70 B | |
| 2011-12-31 | N/A |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 | ₹4.08 B | -96.83% | 🇺🇸 USA |
 | ₹2.878 T | 2,134.31% | 🇺🇸 USA |
 | ₹1.150 T | 793.15% | 🇺🇸 USA |
 | ₹5.445 T | 4,126.92% | 🇺🇸 USA |
 | ₹1.594 T | 1,137.44% | 🇫🇷 France |
 | ₹3.134 T | 2,332.86% | 🇺🇸 USA |